Effectiveness of the 2024-2025 KP.2 COVID-19 vaccines in the United States during long-term follow-up. - Ioannou GN; Berry K; Yan L; Huang Y; Lin HM; Bui D; Hynes DM; Boyko EJ; Ferguson JM; Aslan M; Bajema KL (Nature communications, 2025)